Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00479726 · ClinicalTrials.gov registry record · Phase 4
Lilly's Emotional and Physical Symptoms of Depression Study (LEAPS)
A Phase 4 study, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- Phase 4
- Development phase
- 8,000
- Enrollment target
NCT00479726 is a Phase 4 study that has completed, run by Eli Lilly and Company. The registered enrollment target is 8,000 participants.
The verdict
NCT00479726, a Phase 4 study, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 8,000 participants
- Enrollment target
Study Summary
To assess the effectiveness of duloxetine administered once daily in patients with Major Depressive Disorder in a practice based setting
Interventions
- DRUG duloxetine hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8,000 participants |
| Start Date | 2004-08 |
| Est. Completion | 2005-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00479726
The ClinicalTrials.gov registry entry for NCT00479726 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 8,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which duloxetine hydrochloride is the first listed.
NCT00479726 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00479726 about?
NCT00479726 is a clinical study titled "Lilly's Emotional and Physical Symptoms of Depression Study (LEAPS)". To assess the effectiveness of duloxetine administered once daily in patients with Major Depressive Disorder in a practice based setting
What is the current status of trial NCT00479726?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 8,000 participants. The study started on 2004-08. Estimated completion is 2005-01.
What interventions are being tested in trial NCT00479726?
The interventions under investigation include: duloxetine hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00479726?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.